Behind the Science - Season 1

A panel of experts joins Behind the Science to discuss the explosion of telehealth during the COVID-19 pandemic.

Experts discuss their views on if the United States has seen robust uptake of biosimilars or if we need to wait to see the results.

New research shows disparities were found when diagnostic and treatment information from patients with bladder cancer was prospectively assessed.

A panel of experts joins Behind the Science to give their mental health care predictions.

A panel of experts joins Behind the Science to discuss the rising prevalence of diabetes in the US population—one which is also aging toward greater diabetes-driven vision impairment risks including diabetic retinopathy and diabetic macular edema—has physicians wondering why there’s not more collaboration between ophthalmology and diabetes specialists who are often treating the same patients.

With issues surrounding health care cost and coverage being further exacerbated amid the COVID-19 pandemic, a recent survey by Kaiser Family Foundation and the Purchaser Business Group on Health indicates that a majority of executive decision-makers at large employers would support greater government intervention to address these concerns.

A panel of experts joins Behind the Science to give their reactions to the links between the Johnson & Johnson and cerebral venous sinus thrombosis (CVST).

A panel of experts joins Behind the Science to discuss COVID-19 vaccine hesitancy in the oncology practice.

A panel of experts joins Behind the Science to discuss new evidence showing why night shift workers are at increased risk of developing certain types of cancer.

Five experts from throughout the healthcare continuum join Behind the Science to discuss the value of the pharmacist in various aspects of the COVID-19 vaccination process in the United States.

A panel of Ophthalmology experts join Behind the Science to discuss the cases that keep them up at night.

A panel of experts joins Behind the Science to discuss the advice they would give to someone who may be grappling with a new diagnosis of cancer

Industry thought leaders join Behind the Science to review some of the highlights from the first week’s presentations from the 2021 American Association for Cancer Research Annual Meeting.

A panel of experts joins Behind the Science to discuss the disruption the COVID-19 pandemic had on the ophthalmology world.